Machine learning approaches improve risk stratification for secondary cardiovascular disease prevention in multiethnic patients

QR Code

Machine learning approaches improve risk stratification for secondary cardiovascular disease prevention in multiethnic patients

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Jiang Li, Fátima Rodriguez, Andrew Ward, Ashish Sarraju, David Scheinker, Sukyung Chung
Format:	article
Langue:	EN
Publié:	BMJ Publishing Group 2021
Sujets:	Diseases of the circulatory (Cardiovascular) system RC666-701
Accès en ligne:	https://doaj.org/article/aa43a258da2a4b6e96f81029a475255e
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Secondary Prevention of Cardiovascular Disease in Women: Closing the Gap
par: Aarti Thakkar, et autres
Publié: (2021)

Sudden Cardiac Death Risk Stratification and Prevention in Chagas Disease: A Non-systematic Review of the Literature
par: Roberto Keegan, et autres
Publié: (2020)

Insights for Stratification of Risk in Brugada Syndrome
par: Daniel García Iglesias, et autres
Publié: (2019)

Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy
par: Ryan Wallace, et autres
Publié: (2021)

Time to reconsider risk stratification in dilated cardiomyopathy
par: A. Laina, et autres
Publié: (2021)

Brugada Syndrome: Progress in Genetics, Risk Stratification and Management
par: Jorge Romero, et autres
Publié: (2019)

The Role of C-reactive Protein in Patient Risk Stratification and Treatment
par: Ramón Arroyo-Espliguero, et autres
Publié: (2021)

Obstructive Sleep Apnoea Syndrome: Continuous Positive Airway Pressure Therapy for Prevention of Cardiovascular Risk
par: María Pilar Resano-Barrio, et autres
Publié: (2020)

Hypertensive Disorders in Pregnancy and the Risk of Cardiovascular Disease: A Need for Postpartum Strategies for the Primary Prevention
par: Ajay K. Gupta
Publié: (2018)

Utility of Blood Cellular Indices in the Risk Stratification of Patients Presenting with Acute Pulmonary Embolism
par: Brett Slajus MPH, et autres
Publié: (2021)

Cardiovascular Imaging and Theranostics in Cardiovascular Pharmacotherapy
par: Mattia Cattaneo, et autres
Publié: (2019)

Transcatheter Aortic Valve Implantation and Subclinical and Clinical Leaflet Thrombosis: Multimodality Imaging for Diagnosis and Risk Stratification
par: María Martín, et autres
Publié: (2021)

Cardiovascular disease and nutrition: The use of food-based dietary guidelines for prevention in Africa
par: P.T. Pisa, et autres
Publié: (2017)

ESTIMATED AGGREGATE TREATMENT BENEFIT WITH ADDITION OF MULTIPLE NOVEL MEDICATIONS FOR SECONDARY PREVENTION OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
par: Robert W. Ariss, et autres
Publié: (2021)

Comorbidity Differentiation and Risk Stratification in the Elderly Patient with Polypharmacy: A Prospective Primary Care Registry on Oral Anticoagulation Therapy
par: S van Vugt, et autres
Publié: (2020)

Contemporary Management of Secondary Mitral Regurgitation
par: Kashish Goel, et autres
Publié: (2020)

Cardiovascular Pharmacotherapy Focus
par: Pablo Avanzas
Publié: (2019)

Inflammation and Cardiovascular Disease: The Future
par: Natalie Arnold, et autres
Publié: (2021)

The Effect of Testosterone on Cardiovascular Disease and Cardiovascular Risk Factors in Men: A Review of Clinical and Preclinical Data
par: Hargun Kaur, et autres
Publié: (2021)

Meditation and Cardiovascular Health: What is the Link?
par: Sebastian Schnaubelt, et autres
Publié: (2019)

COVID-19 Pandemic and Cardiovascular Disease
par: Aniket S Rali, et autres
Publié: (2020)

Deciphering the Riddles in Nutrition and Cardiovascular Disease
par: Amelia Carro, et autres
Publié: (2019)

The Association Between Psoriasis and Cardiovascular Diseases
par: Ahmed Zwain, et autres
Publié: (2021)

Effects of aerospace environments on the cardiovascular system
par: Erdinç Ercan
Publié: (2021)

Post-thrombotic Syndrome: Preventative and Risk Reduction Strategies Following Deep Vein Thrombosis
par: Adam M Gwozdz, et autres
Publié: (2020)

Novel Cardiovascular Biomarkers Associated with Increased Cardiovascular Risk in Women With Prior Preeclampsia/HELLP Syndrome: A Narrative Review
par: Esmee ME Bovee, et autres
Publié: (2021)

Assessment of awareness of risk factors and heart healthy lifestyle as a part of routine cardiovascular evaluation in secondary prevention
par: Meral Kayıkçıoğlu
Publié: (2021)

New Perspectives on Atherogenic Dyslipidaemia and Cardiovascular Disease
par: Alberto J Lorenzatti, et autres
Publié: (2020)

Viscoelastic Haemostatic Assays in Cardiovascular Critical Care
par: Aniket S Rali, et autres
Publié: (2021)

Applications of Machine Learning in Cardiac Electrophysiology
par: Rahul G Muthalaly, et autres
Publié: (2020)

Electronic Cigarettes and Cardiovascular Risk: Caution Waiting for Evidence
par: Domenico D’Amario, et autres
Publié: (2019)

Cardiovascular Outcomes in Trials of New Antidiabetic Drug Classes
par: Chris Wai Hang Lo, et autres
Publié: (2021)

Coronavirus Disease 2019: Psychological Stress and Cardiovascular Diseases
par: Maki Komiyama, et autres
Publié: (2021)

The Fourth Trimester: Pregnancy as a Predictor of Cardiovascular Disease
par: Pensée Wu, et autres
Publié: (2021)

New opportunities for reducing cardiovascular risk in the Russian Federation
par: O. D. Ostroumova, et autres
Publié: (2020)

Biomarker profile and risk stratification in cardiovascular disease during pregnancy: Action to move forward
par: Hasan Ali Farhan, et autres
Publié: (2021)

Obesity and Cardiovascular Risk After Quitting Smoking: The Latest Evidence
par: Koji Hasegawa, et autres
Publié: (2019)

Electronic Cigarettes and Cardiovascular Risk: Science, Policy and the Cost of Certainty
par: Olusola A Orimoloye, et autres
Publié: (2019)

Non-invasive Low-level Tragus Stimulation in Cardiovascular Diseases
par: Yunqiu Jiang, et autres
Publié: (2020)

Anti-inflammatory Treatment and Cardiovascular Outcomes: Results of Clinical Trials
par: Alberto J Lorenzatti
Publié: (2021)